Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10

Thinking a bit more about the quarterly for some reason and the $23k in production costs is not a good sign for future sales in the short term at least. You can't be sure which of their edible products these costs are associated with to see any market indications.

Looking at old mate HCT - they have a $12.39m market cap, cash sales of $2.074m for the quarter and a $266k cash deficit for the quarter.
SKN - $22.09m market cap, cash sales of $48k for the quarter ($16k per month) and a $1.120m cash deficit for the quarter.

I have long ago washed my hands of investments in both these companies, and not for an instant saying that HCT is a good investment, but my goodness SKN looks waaaaaay overpriced by comparison. I reckon a price around 0.5c to 1.5c is around the mark until they actually do anything from a sales front.

The latest sales agreement will have them operating on wholesale margins and not retail, so Gross Profits will be significantly lower as well.

Again, just my 2 cents.